|

Drug-Eluting Embolic Bead Clinical Trials

1 actively recruiting trial

Also known as: Irinotecan-loaded drug-eluting beads (DEBIRI) plus systemic chemotherapy +/- targeted therapy

Pipeline

Phase 3: 1

Top Sponsors

  • Tehran University of Medical Sciences1

Indications

  • Liver Disease1
  • Liver Neoplasm1
  • Colorectal Cancer Metastatic1
  • Liver Cancer1
  • Cancer1

Other1 trial

DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.